Lyme Disease Testing

Global Lyme Disease Testing Market to Reach US$18.6 Billion by 2030

The global market for Lyme Disease Testing estimated at US$12.7 Billion in the year 2024, is expected to reach US$18.6 Billion by 2030, growing at a CAGR of 6.6% over the analysis period 2024-2030. IGRA Testing Technology, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$12.4 Billion by the end of the analysis period. Growth in the Other Technologies segment is estimated at 9.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.3 Billion While China is Forecast to Grow at 6.5% CAGR

The Lyme Disease Testing market in the U.S. is estimated at US$3.3 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$3.0 Billion by the year 2030 trailing a CAGR of 6.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.9% and 5.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.4% CAGR.

Global Lyme Disease Testing Market – Key Trends & Drivers Summarized

Why Is Lyme Disease Testing Gaining Importance?

Lyme disease is one of the most common tick-borne illnesses, with cases rising due to climate change and increased outdoor activities in endemic areas. Early and accurate detection of Lyme disease is critical to preventing long-term complications such as neurological and joint issues. As public awareness of tick-borne diseases grows, the demand for advanced and reliable Lyme disease testing is increasing.

How Are Innovations Enhancing the Performance of Lyme Disease Testing?

Advancements in molecular diagnostics, serological assays, and rapid point-of-care testing are improving the accuracy and speed of Lyme disease diagnosis. Next-generation PCR-based tests can detect the Borrelia bacteria at an early stage, reducing false negatives associated with traditional antibody tests. AI-driven diagnostic tools and at-home test kits are also emerging, providing faster and more accessible testing solutions. Additionally, researchers are developing multi-target assays that can distinguish Lyme disease from other tick-borne illnesses.

What Are the Key Market Drivers?

The rising incidence of Lyme disease, increased public health initiatives, and technological advancements in diagnostic methods are key market drivers. Government agencies and research institutions are investing in better diagnostic tools to enable early detection and improve treatment outcomes. The growing trend of outdoor recreational activities and pet ownership has also heightened the need for Lyme disease awareness and testing.

What Challenges and Future Opportunities Exist?

Challenges include the variability in test accuracy, high costs of advanced diagnostic methods, and limited awareness in some regions. However, opportunities exist in developing AI-assisted Lyme disease detection tools, expanding at-home test kit availability, and integrating Lyme disease screening into routine wellness check-ups.

SCOPE OF STUDY:

The report analyzes the Lyme Disease Testing market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Technology (IGRA Testing Technology, Other Technologies); Test (Serological Test, Lymphocytic Transformation Test, Urine Antigen Testing, Immunofluorescent Staining Test, Nucleic Acid Test); Sample (Blood Sample, Urine Sample, CSF Sample, Other Samples); End-Use (Hospitals End-Use, Diagnostic Laboratories End-Use, Other End-Uses)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 32 Featured) -

• Abbott Laboratories
• Affymetrix, Inc.
• bioMérieux SA
• Bio-Rad Laboratories, Inc.
• Ceres Nanosciences
• DiaSorin S.p.A
• F. Hoffmann-La Roche AG
• Galaxy Diagnostics
• Gold Standard Diagnostics
• Graphene Frontiers
• IGeneX, Inc.
• LabCorp
• Meridian Bioscience, Inc.
• Oxford Immunotec
• Quest Diagnostics
• Quidel Corporation
• T2 Biosystems, Inc.
• Thermo Fisher Scientific, Inc.
• Trinity Biotech
• ZEUS Scientific

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.